C12R 1 - Micro-organisms - Patents Sitemap

Patents for C12R 1 - Micro-organisms (92,025)
11/2002
11/19/2002	US6482586 Hybrid compositions for intracellular targeting
11/19/2002	US6482414 Cold-adapted equine influenza viruses
11/19/2002	US6482410 Mediation of neuronal attachment and enhancement of the outgrowth of neutites
11/19/2002	CA2199938C Probe for diagnosing infectious diseases
11/19/2002	CA2108358C Gene expression in bacilli
11/19/2002	CA2091700C A non-mitogenic competitive hgf antagonist
11/19/2002	CA2073095C Gellan gum for non-brittle gels
11/19/2002	CA2040793C Plasmids expressing patatin and adp-glucose-pyrophosphorylase sequences
11/19/2002	CA1341400C Process for preparing proteins
11/19/2002	CA1341399C Intercellular adhesion molecules and their binding ligands
11/19/2002	CA1341398C Expression of biologically active pdgf analogs in eucaryotic cells
11/14/2002	WO2002090560A2 Process for the production of phospholipids
11/14/2002	WO2002081694A8 Method for the sectetion and production of protein
11/14/2002	WO2002074934A8 Thermophilic microorganism bacillus coagulans strain sim-t dsm 14043 for the production of l(+)-lactate from fermentable sugars and their mixtures
11/14/2002	WO2002066628A3 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
11/14/2002	US20020170084 Process for obtaining plant dna fragment and use thereof
11/14/2002	US20020169305 Nucleotide sequences coding polypeptide for use in the treatment and prevention of malaria
11/14/2002	US20020168764 Generation and recovering of preferential viral particles; obtain cells, infect with virus, extract virus from cells using detergent, recover virus
11/14/2002	US20020168736 Nucleotide sequences coding protein for use in the treatment of immunological disorders
11/14/2002	US20020168726 Bacterial antigens and vaccine compositions
11/14/2002	US20020168723 Nucleotide sequences coding protein for use in the treatment of nervous system disorders
11/14/2002	US20020168712 Molecules designated LDCAM
11/14/2002	US20020168708 Nucleotide sequences coding polypeptide for use in the treatment of parkinson's, chronic obstructive airways, irritable bowel syndrome, muscle and urogenital disorders
11/14/2002	US20020168703 Process for the manufacture of carotenoids and biologically useful materials thereof
11/14/2002	US20020168635 Nucleotide sequences coding polypeptides for use in screening modulators of taste
11/14/2002	US20020168415 Biocompatible; culture product; anticancer agents
11/14/2002	US20020168382 Inducing immunology response
11/14/2002	US20020168381 Mixture of bone protein and ethylene oxide-propylene oxide copolymer; in situ administering
11/14/2002	US20020168375 Biosynthetic binding proteins for immuno-targeting
11/14/2002	US20020168345 Methods of monitoring HIV drug resistance using adenoviral vectors
11/13/2002	EP1256606A2 Pigment containing ink and production method thereof
11/13/2002	EP1255868A1 Altered recombinases for genome modification
11/13/2002	EP1255840A2 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility
11/13/2002	EP1255839A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
11/13/2002	EP1255821A2 Protein c derivatives
11/13/2002	EP1255773A2 Insecticidal proteins from bacillus thuringiensis
11/13/2002	EP0693935B1 Method and compositions for digesting tissue
11/13/2002	EP0449958B2 Meningococcal class 1 outer-membrane protein vaccine
11/13/2002	CN1379823A Method for production of L-cysteine or L-cysteine derivatives by fermentation
11/13/2002	CN1379821A Nucleic acid transporter containing polypeptide and recombinant virus vector
11/13/2002	CN1379818A Process for biological production of 1,3-propanediol with high titer
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379683A 疫苗 Vaccine
11/12/2002	US6479735 Transgenic plants including a transgene consisting of a hybrid nucleic acid sequence, comprising at least one unedited mitochondrial gene fragment from higher plants and process for producing them
11/12/2002	US6479643 Single chain analogs of the TGF-β superfamily (morphons)
11/12/2002	US6479630 Human purinergic P2U receptor
11/12/2002	US6479459 Cytokine designated lerk-5
11/12/2002	US6479290 Chimeric adenoviral vectors
11/12/2002	US6479271 Genes encoding desulfurization enzymes
11/12/2002	US6479267 FY7 polymerase
11/12/2002	US6479261 Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells
11/12/2002	US6479250 Eck receptor ligands
11/12/2002	US6479050 Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof
11/12/2002	CA2156486C Mucosal competitive exclusion flora
11/12/2002	CA2115036C Continuous natamycin production
11/12/2002	CA2090493C Process for hydrolyzing hemicellulose by enzymes produced by trichoderma reesei
11/12/2002	CA2077102C Antibiotic ge 2270 factor c2a
11/12/2002	CA2068083C Anti-bacterial compound
11/12/2002	CA2065245C Recombinant negative strand rna virus expression systems and vaccines
11/12/2002	CA2062820C Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
11/12/2002	CA2055963C Chimeric fibroblast growth factor
11/12/2002	CA2045875C Monoclonal antibodies to mycosphaerella species
11/07/2002	WO2002088387A2 Amplification process
11/07/2002	WO2002088373A1 Method for producing an aqueous acrylamide solution with a biocatalyst
11/07/2002	WO2002088371A2 Method for the production of an aqueous acrylamide solution with a bio-catalyst
11/07/2002	WO2002088367A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus
11/07/2002	WO2002088340A2 Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants
11/07/2002	WO2002038785A3 Process for the preparation of trans-carveol
11/07/2002	WO2001027305A9 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms
11/07/2002	US20020166140 Mutated barnase gene and plant transformed by the same
11/07/2002	US20020166131 Nucleotide sequences coding polypeptide for use in the treatment of disease parkinson's, irritable bowel syndrome and cardiovascular disorders
11/07/2002	US20020165378 Human membrane antigen tm4 superfamily protein and dna encoding this protein
11/07/2002	US20020165373 Contacting the sample with an isolated recombinant immunodominant Neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex
11/07/2002	US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders
11/07/2002	US20020165355 Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
11/07/2002	US20020165256 Fermentative preparation process for and crystal forms of cytostatics
11/07/2002	US20020165177 Modified factor VIII cDNA
11/07/2002	US20020164797 Stable in vitro culture of plant cells and phytopathogens for use in the generation of preferential compounds
11/07/2002	US20020164796 Tissue section for use in the propagation, culture and grafting of animal
11/07/2002	US20020164774 Method and compositions for treating cellulose containing fabrics using truncated cellulase enzyme compositions
11/07/2002	US20020164773 Generation of extracellular, polysaccharides of basidiomycetes mushrooms; obtain fungi, propagate in nutrient broths, isolating biomass from culture by precipitation
11/07/2002	US20020164772 Multiple drug resistance gene atrD of aspergillus nidulans
11/07/2002	US20020164771 Methods for lyophilizing competent cells
11/07/2002	US20020164744 Amine oxidase for use in the treatment of alzhemier's, huntington,s and nervous system disorders
11/07/2002	US20020164729 Generating polyhydroxyalkanoates; obtain genetically engineered microorganism which expresses preferential enzymes, incubate with butane, hexane, propane, ethane or pentanediol, culture and recover hydroxyalkanoates
11/07/2002	US20020164728 Process for preparing 4-cyanopentanoic acid
11/07/2002	US20020164726 Polyhydroxyalkanoate for use in culturing microorganisms
11/07/2002	US20020164723 Method of producing saccharide preparations
11/07/2002	US20020164720 Generating 2'-deoxyribonucleoside; obtain microorganism, transform with vector containing ribonucleotide reductase, express vector, incubate with substrate, recover 2'-deoxyribonucleoside
11/07/2002	US20020164711 Megakaryocyte differentiation factor
11/07/2002	US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002	US20020164702 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders
11/07/2002	US20020164700 Metabolic rate shifts in fermentations expressing recombinant proteins
11/07/2002	US20020164690 Receptor based antagonists and methods of making and using
11/07/2002	US20020164682 Mammalian cerberus-like protein and compositions
11/07/2002	US20020164637 Detecting receptor binding ligands; obtain cell extract, incubate with modulator, detect binding, monitor activity from receptor
11/07/2002	US20020164591 Enzymatic polypeptide for use in determining biopolymer sequences
11/07/2002	US20020164337 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
11/07/2002	US20020164334 Antibody-induced apoptosis
11/07/2002	CA2446010A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus

1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 921